Single blind, randomized, actively controlled phase 1/2 study to compare the safety and immunogenicity of a split virus, Vero cell derived, seasonal influenza vaccine (VCIC) with a licensed, egg derived, split virus, seasonal influenza vaccine (EIV)

Trial Profile

Single blind, randomized, actively controlled phase 1/2 study to compare the safety and immunogenicity of a split virus, Vero cell derived, seasonal influenza vaccine (VCIC) with a licensed, egg derived, split virus, seasonal influenza vaccine (EIV)

Completed
Phase of Trial: Phase I/II

Latest Information Update: 14 Oct 2015

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jan 2008 Status change from in progress to completed as reported by clinicaltrials.gov.
    • 10 Aug 2007 Status changed from recruiting to in progress.
    • 23 Jul 2007 Interim results were presented at the Options for the Control of Influenza VI Conference
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top